{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T05:42:53Z","timestamp":1698471773860},"reference-count":67,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2017]]},"DOI":"10.2222\/jsv.67.69","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T23:04:54Z","timestamp":1522278294000},"page":"69-78","source":"Crossref","is-referenced-by-count":1,"title":["Molecular basis for negative-strand RNA virus entry and neutralization by antibodies"],"prefix":"10.2222","volume":"67","author":[{"given":"Takao","family":"HASHIGUCHI","sequence":"first","affiliation":[{"name":"Affiliation; Department of Virology, Faculty of medicine, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","unstructured":"1) Griffin DE. Measles virus, p. 1042-1069. In Knipe DM, Howley PM, J.I. C, Griffin DE, Lamb RA, Martin MA, V.R. R, Roizman B (ed.), Fields Virology. 6 ed. , vol. I. Lippincott Williams & Wilkins, Philadelphia. 2013."},{"key":"2","unstructured":"2) World Health Organization. Measles. 2017."},{"key":"3","unstructured":"3) Rubin SA, Sauder CJ, Carbone KM. Mumps Virus, p. 1024-1041. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed.), Fields Virology. 6 ed., vol. I. Lippincott Williams & Wilkins, Philadelphia. 2013."},{"key":"4","unstructured":"4) Feldmann H, Sanchez A, Geisbert TW. Filoviridae: Marburg and Ebola Viruses, p. 923-956. In Knipe DM, Howley PM, J.I. C, Griffin DE, Lamb RA, Martin MA, V.R. R, Roizman B (ed.), Fields Virology. 6 ed. , vol. I. Lippincott Williams & Wilkins, Philadelphia. 2013."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) World Health Organization. Ebola Situation Reports. 2016.","DOI":"10.1017\/9781316488485"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514:47-53. 2014.","DOI":"10.1038\/nature13777"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, Kraft CS, Towner JS, Spiropoulou C, Stroher U, Uyeki TM, Ribner BS, Emory Serious Communicable Diseases U. Clinical care of two patients with Ebola virus disease in the United States. The New England journal of medicine 371:2402-2409. 2014.","DOI":"10.1056\/NEJMoa1409838"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406: 893-897. 2000.","DOI":"10.1038\/35022579"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Noyce RS, Bondre DG, Ha MN, Lin LT, Sisson G, Tsao MS, Richardson CD. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog 7:e1002240. 2011.","DOI":"10.1371\/journal.ppat.1002240"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Muhlebach MD, Mateo M, Sinn PL, Prufer S, Uhlig KM, Leonard VH, Navaratnarajah CK, Frenzke M, Wong XX, Sawatsky B, Ramachandran S, McCray PB, Cichutek K, von Messling V, Lopez M, Cattaneo R. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature. 2011.","DOI":"10.1038\/nature10639"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yanagi Y, Takeda M, Ohno S, Hashiguchi T. Measles virus receptors. Curr Top Microbiol Immunol 329:13-30. 2009.","DOI":"10.1007\/978-3-540-70523-9_2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Takeda M, Tahara M, Hashiguchi T, Sato TA, Jinnouchi F, Ueki S, Ohno S, Yanagi Y. A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J Virol 81:12091-12096. 2007.","DOI":"10.1128\/JVI.01264-07"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Leonard VH, Sinn PL, Hodge G, Miest T, Devaux P, Oezguen N, Braun W, McCray PB, Jr., McChesney MB, Cattaneo R. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J Clin Invest 118:2448-2458. 2008.","DOI":"10.1172\/JCI35454"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032. 1993.","DOI":"10.1128\/JVI.67.10.6025-6032.1993"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295-305. 1993.","DOI":"10.1016\/0092-8674(93)80071-L"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, Kohda D, Yanagi Y, Maenaka K. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A 104:19535-19540. 2007.","DOI":"10.1073\/pnas.0707830104"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Hashiguchi T, Ose T, Kubota M, Maita N, Kamishikiryo J, Maenaka K, Yanagi Y. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol 18:135-141. 2011.","DOI":"10.1038\/nsmb.1969"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hashiguchi T, Maenaka K, Yanagi Y. Measles virus hemagglutinin: structural insights into cell entry and measles vaccine. Frontiers in microbiology 2:247. 2011.","DOI":"10.3389\/fmicb.2011.00247"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nakashima M, Shirogane Y, Hashiguchi T, Yanagi Y. Mutations in the putative dimer-dimer interfaces of the measles virus hemagglutinin head domain affect membrane fusion triggering. J Biol Chem 288:8085-8091. 2013.","DOI":"10.1074\/jbc.M112.427609"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kubota M, Takeuchi K, Watanabe S, Ohno S, Matsuoka R, Kohda D, Nakakita SI, Hiramatsu H, Suzuki Y, Nakayama T, Terada T, Shimizu K, Shimizu N, Shiroishi M, Yanagi Y, Hashiguchi T. Trisaccharide containing alpha2,3-linked sialic acid is a receptor for mumps virus. Proc Natl Acad Sci U S A. 2016.","DOI":"10.1073\/pnas.1608383113"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) de Swart RL, Yuksel S, Osterhaus AD. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J Virol 79:11547-11551. 2005.","DOI":"10.1128\/JVI.79.17.11547-11551.2005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, Duprex WP. Recent mumps outbreaks in vaccinated populations: No evidence of immune escape. J. Virol. 86:615-620. 2012.","DOI":"10.1128\/JVI.06125-11"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Rydbeck R, Löve A, Örvell C, Norrby E. Antigenic variation of envelope and internal proteins of mumps virus strains detected with monoclonal antibodies. J. Gen. Virol. 67:281-287. 1986.","DOI":"10.1099\/0022-1317-67-2-281"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Örvell C, Alsheikhly AR, Kalantari M, Johansson B. Characterization of genotype-specific epitopes of the HN protein of mumps virus. J. Gen. Virol. 78 3187-3193. 1997.","DOI":"10.1099\/0022-1317-78-12-3187"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Latner DR, Hickman CJ. Remembering mumps. PLoS Pathog. 11:e1004791. 2015.","DOI":"10.1371\/journal.ppat.1004791"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Yoshida N, Fujino M, Miyata A, Nagai T, Kamada M, Sakiyama H, Ihara T, Kumagai T, Okafuji T, Okafuji T, Nakayama T. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. J. Med. Virol. 80:517-523. 2008.","DOI":"10.1002\/jmv.21106"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proceedings of the National Academy of Sciences of the United States of America 93:3602-3607. 1996.","DOI":"10.1073\/pnas.93.8.3602"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Sanchez A, Trappier SG, Stroher U, Nichol ST, Bowen MD, Feldmann H. Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology 240:138-146. 1998.","DOI":"10.1006\/viro.1997.8902"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Volchkov VE, Volchkova VA, Stroher U, Becker S, Dolnik O, Cieplik M, Garten W, Klenk HD, Feldmann H. Proteolytic processing of Marburg virus glycoprotein. Virology 268:1-6. 2000.","DOI":"10.1006\/viro.1999.0110"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Jeffers SA, Sanders DA, Sanchez A. Covalent modifications of the ebola virus glycoprotein. Journal of virology 76:12463-12472. 2002.","DOI":"10.1128\/JVI.76.24.12463-12472.2002"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Manicassamy B, Wang J, Rumschlag E, Tymen S, Volchkova V, Volchkov V, Rong L. Characterization of Marburg virus glycoprotein in viral entry. Virology 358:79-88. 2007.","DOI":"10.1016\/j.virol.2006.06.041"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Takada A, Fujioka K, Tsuiji M, Morikawa A, Higashi N, Ebihara H, Kobasa D, Feldmann H, Irimura T, Kawaoka Y. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. Journal of virology 78:2943-2947. 2004.","DOI":"10.1128\/JVI.78.6.2943-2947.2004"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nature medicine 6:886-889. 2000.","DOI":"10.1038\/78654"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Francica JR, Varela-Rohena A, Medvec A, Plesa G, Riley JL, Bates P. Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein. PLoS pathogens 6:e1001098. 2010.","DOI":"10.1371\/journal.ppat.1001098"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Noyori O, Matsuno K, Kajihara M, Nakayama E, Igarashi M, Kuroda M, Isoda N, Yoshida R, Takada A. Differential potential for envelope glycoprotein-mediated steric shielding of host cell surface proteins among filoviruses. Virology 446:152-161. 2013.","DOI":"10.1016\/j.virol.2013.07.029"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Alvarez CP, Lasala F, Carrillo J, Muniz O, Corbi AL, Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. Journal of virology 76:6841-6844. 2002.","DOI":"10.1128\/JVI.76.13.6841-6844.2002"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Gramberg T, Hofmann H, Moller P, Lalor PF, Marzi A, Geier M, Krumbiegel M, Winkler T, Kirchhoff F, Adams DH, Becker S, Munch J, Pohlmann S. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 340:224-236. 2005.","DOI":"10.1016\/j.virol.2005.06.026"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Becker S, Spiess M, Klenk HD. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. The Journal of general virology 76 ( Pt 2):393-399. 1995.","DOI":"10.1099\/0022-1317-76-2-393"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Adachi H, Takano K, Morikawa M, Kanaya S, Yoshimura M, Mori Y, Sasaki T. Application of a two-liquid system to sitting-drop vapour-diffusion protein crystallization. Acta Crystallogr D Biol Crystallogr 59:194-196. 2003.","DOI":"10.1107\/S0907444902019741"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Marzi A, Moller P, Hanna SL, Harrer T, Eisemann J, Steinkasserer A, Becker S, Baribaud F, Pohlmann S. Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR. The Journal of infectious diseases 196 Suppl 2:S237-246. 2007.","DOI":"10.1086\/520607"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Marzi A, Gramberg T, Simmons G, Moller P, Rennekamp AJ, Krumbiegel M, Geier M, Eisemann J, Turza N, Saunier B, Steinkasserer A, Becker S, Bates P, Hofmann H, Pohlmann S. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. Journal of virology 78:12090-12095. 2004.","DOI":"10.1128\/JVI.78.21.12090-12095.2004"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, Moller-Tank S, Meyerholz DK, Rennert P, Mullins RF, Brindley M, Sandersfeld LM, Quinn K, Weller M, McCray PB, Jr., Chiorini J, Maury W. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proceedings of the National Academy of Sciences of the United States of America 108:8426-8431. 2011.","DOI":"10.1073\/pnas.1019030108"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Kuroda M, Fujikura D, Nanbo A, Marzi A, Noyori O, Kajihara M, Maruyama J, Matsuno K, Miyamoto H, Yoshida R, Feldmann H, Takada A. Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus. Journal of virology 89:6481-6493. 2015.","DOI":"10.1128\/JVI.03156-14"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS pathogens 6:e1001121. 2010.","DOI":"10.1371\/journal.ppat.1001121"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, Jones S, Feldmann H, Kawaoka Y. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. Journal of virology 80:10109-10116. 2006.","DOI":"10.1128\/JVI.01157-06"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Brindley MA, Hunt CL, Kondratowicz AS, Bowman J, Sinn PL, McCray PB, Jr., Quinn K, Weller ML, Chiorini JA, Maury W. Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology 415:83-94. 2011.","DOI":"10.1016\/j.virol.2011.04.002"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645. 2005.","DOI":"10.1126\/science.1110656"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278:20-26. 2000.","DOI":"10.1006\/viro.2000.0601"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Schornberg KL, Shoemaker CJ, Dube D, Abshire MY, Delos SE, Bouton AH, White JM. Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins. Proceedings of the National Academy of Sciences of the United States of America 106:8003-8008. 2009.","DOI":"10.1073\/pnas.0807578106"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477:340-343. 2011.","DOI":"10.1038\/nature10348"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Cote M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477:344-348. 2011.","DOI":"10.1038\/nature10380"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Brecher M, Schornberg KL, Delos SE, Fusco ML, Saphire EO, White JM. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. Journal of virology 86:364-372. 2012.","DOI":"10.1128\/JVI.05708-11"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Takada A, Feldmann H, Ksiazek TG, Kawaoka Y. Antibody-dependent enhancement of Ebola virus infection. Journal of virology 77:7539-7544. 2003.","DOI":"10.1128\/JVI.77.13.7539-7544.2003"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Nakayama E, Tomabechi D, Matsuno K, Kishida N, Yoshida R, Feldmann H, Takada A. Antibody-dependent enhancement of Marburg virus infection. The Journal of infectious diseases 204 Suppl 3:S978-985. 2011.","DOI":"10.1093\/infdis\/jir334"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Hashiguchi T, Fusco ML, Bornholdt ZA, Lee JE, Flyak AI, Matsuoka R, Kohda D, Yanagi Y, Hammel M, Crowe JE, Jr., Saphire EO. Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell 160:904-912. 2015.","DOI":"10.1016\/j.cell.2015.01.041"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Funke C, Becker S, Dartsch H, Klenk HD, Muhlberger E. Acylation of the Marburg virus glycoprotein. Virology 208:289-297. 1995.","DOI":"10.1006\/viro.1995.1151"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Valmas C, Grosch MN, Schumann M, Olejnik J, Martinez O, Best SM, Krahling V, Basler CF, Muhlberger E. Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS pathogens 6:e1000721. 2010.","DOI":"10.1371\/journal.ppat.1000721"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Gnirss K, Kuhl A, Karsten C, Glowacka I, Bertram S, Kaup F, Hofmann H, Pohlmann S. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. Virology 424:3-10. 2012.","DOI":"10.1016\/j.virol.2011.11.031"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Misasi J, Chandran K, Yang JY, Considine B, Filone CM, Cote M, Sullivan N, Fabozzi G, Hensley L, Cunningham J. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. Journal of virology 86:3284-3292. 2012.","DOI":"10.1128\/JVI.06346-11"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Wang H, Shi Y, Song J, Qi J, Lu G, Yan J, Gao GF. Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1. Cell 164:258-268. 2016.","DOI":"10.1016\/j.cell.2015.12.044"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177-182. 2008.","DOI":"10.1038\/nature07082"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Dias JM, Kuehne AI, Abelson DM, Bale S, Wong AC, Halfmann P, Muhammad MA, Fusco ML, Zak SE, Kang E, Kawaoka Y, Chandran K, Dye JM, Saphire EO. A shared structural solution for neutralizing ebolaviruses. Nat Struct Mol Biol 18:1424-1427. 2011.","DOI":"10.1038\/nsmb.2150"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Bale S, Dias JM, Fusco ML, Hashiguchi T, Wong AC, Liu T, Keuhne AI, Li S, Woods VL, Jr., Chandran K, Dye JM, Saphire EO. Structural basis for differential neutralization of ebolaviruses. Viruses 4:447-470. 2012.","DOI":"10.3390\/v4040447"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Murin CD, Fusco ML, Bornholdt ZA, Qiu X, Olinger GG, Zeitlin L, Kobinger GP, Ward AB, Saphire EO. Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proceedings of the National Academy of Sciences of the United States of America 111:17182-17187. 2014.","DOI":"10.1073\/pnas.1414164111"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Bornholdt ZA, Turner HL, Murin CD, Li W, Sok D, Souders CA, Piper AE, Goff A, Shamblin JD, Wollen SE, Sprague TR, Fusco ML, Pommert KB, Cavacini LA, Smith HL, Klempner M, Reimann KA, Krauland E, Gerngross TU, Wittrup KD, Saphire EO, Burton DR, Glass PJ, Ward AB, Walker LM. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science 351:1078-1083. 2016.","DOI":"10.1126\/science.aad5788"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Flyak AI, Ilinykh PA, Murin CD, Garron T, Shen X, Fusco ML, Hashiguchi T, Bornholdt ZA, Slaughter JC, Sapparapu G, Klages C, Ksiazek TG, Ward AB, Saphire EO, Bukreyev A, Crowe JE, Jr. Mechanism of human antibody-mediated neutralization of marburg virus. Cell 160:893-903. 2015.","DOI":"10.1016\/j.cell.2015.01.031"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Fusco ML, Hashiguchi T, Cassan R, Biggins JE, Murin CD, Warfield KL, Li S, Holtsberg FW, Shulenin S, Vu H, Olinger GG, Kim DH, Whaley KJ, Zeitlin L, Ward AB, Nykiforuk C, Aman MJ, Berry JD, Saphire EO. Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs. PLoS pathogens 11:e1005016. 2015.","DOI":"10.1371\/journal.ppat.1005016"}],"container-title":["Uirusu"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/67\/1\/67_69\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T11:37:18Z","timestamp":1604057838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/67\/1\/67_69\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.67.69","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"value":"0042-6857","type":"print"},{"value":"1884-3433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}